- Home
- ETON vs SHBI Comparison
ETON vs SHBI Comparison
Compare ETON & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- SHBI
- Stock Information
- Founded
- ETON 2017
- SHBI 1876
- Country
- ETON United States
- SHBI United States
- Employees
- ETON N/A
- SHBI N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- SHBI Major Banks
- Sector
- ETON Health Care
- SHBI Finance
- Exchange
- ETON Nasdaq
- SHBI Nasdaq
- Market Cap
- ETON 428.5M
- SHBI 415.6M
- IPO Year
- ETON 2018
- SHBI N/A
- Fundamental
- Price
- ETON $16.84
- SHBI $14.79
- Analyst Decision
- ETON Strong Buy
- SHBI Buy
- Analyst Count
- ETON 3
- SHBI 2
- Target Price
- ETON $29.67
- SHBI $20.00
- AVG Volume (30 Days)
- ETON 440.2K
- SHBI 103.6K
- Earning Date
- ETON 05-13-2025
- SHBI 07-24-2025
- Dividend Yield
- ETON N/A
- SHBI 3.25%
- EPS Growth
- ETON N/A
- SHBI 241.50
- EPS
- ETON N/A
- SHBI 1.48
- Revenue
- ETON $48,327,000.00
- SHBI $201,667,000.00
- Revenue This Year
- ETON $103.21
- SHBI $6.10
- Revenue Next Year
- ETON $51.34
- SHBI $7.16
- P/E Ratio
- ETON N/A
- SHBI $9.77
- Revenue Growth
- ETON 40.88
- SHBI 37.93
- 52 Week Low
- ETON $3.18
- SHBI $10.36
- 52 Week High
- ETON $21.48
- SHBI $17.61
- Technical
- Relative Strength Index (RSI)
- ETON 42.38
- SHBI 58.54
- Support Level
- ETON $19.56
- SHBI $14.35
- Resistance Level
- ETON $19.35
- SHBI $14.79
- Average True Range (ATR)
- ETON 1.07
- SHBI 0.30
- MACD
- ETON -0.47
- SHBI -0.06
- Stochastic Oscillator
- ETON 6.78
- SHBI 73.08
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in two business segments - community banking and mortgage banking. Community banking is conducted through the Bank and involves delivering a broad range of financial services, including lending and deposit-taking, to individuals and commercial enterprises, it also includes treasury and administrative functions. Mortgage banking is conducted through the Bank's secondary marketing department and involves originating first and second-lien residential mortgages for sale in the secondary market.